VHCP Co-Investment Holdings II, LLC's Net Worth
$618 Million
Who is VHCP Co-Investment Holdings II, LLC?
VHCP Co-Investment Holdings II, LLC has an estimated net worth of $618 Million. This is based on reported shares across multiple companies, which include Shockwave Medical, Inc., CONSTELLATION PHARMACEUTICALS INC, KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..
SEC CIK
VHCP Co-Investment Holdings II, LLC's CIK is 0001615983
Past Insider Trading and Trends
2022 was VHCP Co-Investment Holdings II, LLC's most active year for acquiring shares with 46 total transactions. VHCP Co-Investment Holdings II, LLC's most active month to acquire stocks was the month of May. 2019 was VHCP Co-Investment Holdings II, LLC's most active year for disposing of shares, totalling 4 transactions. VHCP Co-Investment Holdings II, LLC's most active month to dispose stocks was the month of September. 2019 saw VHCP Co-Investment Holdings II, LLC paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 VHCP Co-Investment Holdings II, LLC cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARCA biopharma, Inc. (ABIO) Snapshot price: $1.6166
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.54M |
$0.55 | -$846,905.43 |
0
|
Feb 26 - Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.06% | 400K |
$34.50 | $13,800,000.00 | 4.02M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Shockwave Medical, Inc. (SWAV) Snapshot price: $235.415
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.12M |
—
|
—
| 2.12M |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.46% | -500.00K |
$28.75 | -$14,375,000.00 | 1.54M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Altimmune, Inc. (ALT) Snapshot price: $10.445
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -1.00M |
—
|
—
| 3.5M |
Feb 25
| |||
Form 4
| +50.00% | 1.5M |
$7.54 | $11,310,000.00 | 4.5M |
Jun 15
| |||
Form 4
| +76.85% | 1.3M |
$8.74 | $11,395,493.13 | 3M |
May 26 - May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||